Open | $11.870 |
Close | $11.760 |
Volume / Avg. | 8.545M / 10.522M |
Day Range | 11.715 - 11.940 |
52 Wk Range | 8.740 - 13.618 |
Market Cap | $13.930B |
P/E Ratio | 238.700 |
Dividend Yield | 4.020% |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | % |
Days to Cover | 4.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viatris (NASDAQ: VTRS) through any online brokerage.
Other companies in Viatris’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), CymaBay Therapeutics (NASDAQ:CBAY) and Novartis (NYSE:NVS).
The latest price target for Viatris (NASDAQ: VTRS) was reported by Piper Sandler on Wednesday, November 22, 2023. The analyst firm set a price target for 11.00 expecting VTRS to fall to within 12 months (a possible -6.22% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Viatris (NASDAQ: VTRS) is $11.73 last updated March 18, 2024 at 5:49 PM EDT.
A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on March 18, 2024 to stockholders of record on March 8, 2024.
Viatris’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Viatris.
Viatris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.